1. Home
  2. AFMD vs YYAI Comparison

AFMD vs YYAI Comparison

Compare AFMD & YYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFMD
  • YYAI
  • Stock Information
  • Founded
  • AFMD 2000
  • YYAI 2015
  • Country
  • AFMD Germany
  • YYAI Hong Kong
  • Employees
  • AFMD N/A
  • YYAI N/A
  • Industry
  • AFMD Biotechnology: Pharmaceutical Preparations
  • YYAI
  • Sector
  • AFMD Health Care
  • YYAI
  • Exchange
  • AFMD Nasdaq
  • YYAI NYSE
  • Market Cap
  • AFMD 14.5M
  • YYAI 12.1M
  • IPO Year
  • AFMD 2014
  • YYAI N/A
  • Fundamental
  • Price
  • AFMD $0.72
  • YYAI $0.84
  • Analyst Decision
  • AFMD Strong Buy
  • YYAI
  • Analyst Count
  • AFMD 5
  • YYAI 0
  • Target Price
  • AFMD $13.50
  • YYAI N/A
  • AVG Volume (30 Days)
  • AFMD 86.2K
  • YYAI 327.3K
  • Earning Date
  • AFMD 04-08-2025
  • YYAI 03-24-2025
  • Dividend Yield
  • AFMD N/A
  • YYAI N/A
  • EPS Growth
  • AFMD N/A
  • YYAI N/A
  • EPS
  • AFMD N/A
  • YYAI N/A
  • Revenue
  • AFMD $6,287,085.00
  • YYAI N/A
  • Revenue This Year
  • AFMD N/A
  • YYAI N/A
  • Revenue Next Year
  • AFMD $225.65
  • YYAI N/A
  • P/E Ratio
  • AFMD N/A
  • YYAI N/A
  • Revenue Growth
  • AFMD N/A
  • YYAI N/A
  • 52 Week Low
  • AFMD $0.70
  • YYAI $0.35
  • 52 Week High
  • AFMD $8.95
  • YYAI $53.00
  • Technical
  • Relative Strength Index (RSI)
  • AFMD 30.95
  • YYAI 53.33
  • Support Level
  • AFMD $0.85
  • YYAI $0.76
  • Resistance Level
  • AFMD $0.89
  • YYAI $1.08
  • Average True Range (ATR)
  • AFMD 0.05
  • YYAI 0.10
  • MACD
  • AFMD -0.01
  • YYAI 0.01
  • Stochastic Oscillator
  • AFMD 22.75
  • YYAI 43.79

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

About YYAI CONNEXA SPORTS TECHNOLOGIES IN

Connexa Sports Technologies Inc operates in the sports equipment and technology business. It is a connected sports company delivering products, technologies, and services across the Watch, Play, Learn commercial and subscription-as-a-service activities in sports. The company's offerings include Slinger Launcher, which is comprised of a portable tennis ball launcher, a portable padel tennis ball launcher, and a portable pickleball launcher. Through Gameface, it provides AI technology and performance analytics.

Share on Social Networks: